NMS Labs Webinars and Presentations
presentation_icon2.jpg

Toxicological Aspects of Synthetic Drugs

Presented April 2013 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services, at the Seminar on Emerging Trends in Synthetic Drugs Workshop hosted by the National Institute of Standards and Technology (NIST), in collaboration with the Drug Enforcement Administration (DEA) (Request a copy of the presentation)

presentation_icon2.jpg

The Analog Dilemma with Synthetic Cannabinoids

Presented April 23, 2013 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services
(Request a copy of the presentation)

presentation_icon2.jpg

Increasing Diversity of Chemicals in Synthetic Stimulant and Cathinone Cases

Presented November 27, 2012 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

presentation_icon2.jpg

Challenges of Method Validation for Hallucinogens & Designer Stimulants in Biological Samples Using LC-TOF

Hosted by Agilent Technologies, October 8, 2012
Presented by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

presentation_icon2.jpg

Briefing on Synthetic and Designer Drugs

U.S. Rep. Patrick Meehan's Synthetic Drug Use Forum, May 29, 2012
Presented by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

presentation_icon2.jpg

Trends Report on Changes in the Designer Drug Market: Spring 2012

A live webinar hosted on May 23, 2012 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services


presentation_icon2.jpg

The Challenges of Analytical Method Validation of Designer Drugs in Non-Biological Samples by GC/MS

Hosted by Agilent Technologies, May 15, 2012
Presented by Fran Diamond, NMS Labs Chemistry Technical Leader

presentation_icon2.jpg

Pharmacodynamics and Pharmacokinetics of Synthetic Cannabinoids

Presented at the AAFS Annual Conference, February 2012, by Dr. Barry K. Logan, Dr. Wendy Adams


presentation_icon2.jpg

Designer Drugs Testing Solutions for Employers

Presented February 1, 2012 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services


presentation_icon2.jpg

The Expanding Reach of the Designer Drug Movement in 2011: Analytical and Interpretive Challenges for
Forensic Toxicology and Chemistry

A live webinar hosted on October 26, 2011 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

presentation_icon2.jpg

Developments in Toxicology Support for the DRE Community

Co-hosted by NMS Labs and Draeger Safety Diagnostics, Inc., July 2011
 Presented by Dr. Barry K. Logan

presentation_icon2.jpg

Oral Fluid as a Chemical Test for the DRE Program: History, the Future, and Practical Considerations

Presented at the IACP-DRE Conference, July 2011, by Dr. Barry K. Logan


presentation_icon2.jpg

Identification of Markers of JWH-018 and JWH-073 Use in Human Urine

by Sherri L. Kacinko, Allan Xu, Matthew M. McMullin, Barry K. Logan


presentation_icon2.jpg

K2 and Beyond: A Synthetic Cannabinoid Primer

Presented at the AAFS Annual Conference, February 2011 ,by Dr. Barry K. Logan, Lindsay Reinhold, Dr. Sherri Kacinko


presentation_icon2.jpg

K2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical Analysis webinar

Presented September 16, 2010 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services


presentation_icon2.jpg

Salvia - Effects, Legal Status and Analysis webinar

Presented March 18, 2010 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services


presentation_icon2.jpg

New Highs: Salvia and K2 Solutions for the DRE Program

Presented July 2010 at the IACP DRE Conference to Drug Recognition Experts across the nation
by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

presentation_icon2.jpg

Bisphenol-A and Other Suspected Estrogenic Endocrine Disruptors

View presentations from the dinner that NMS Labs hosted during the 2010 Endocrine Society's Annual Meeting